£50 million fund for uni spin-outs
A £50 million venture capital fund to invest in UK university spin-outs has been proposed as a helping hand for the financing of these early-stage companies.
Read MoreAuthor: Katrina Megget
39 drugs approved in the USA in 2012
US Drug approvals in 2012 have reached a 15-year high with regulators giving the thumbs up to 39 new drugs.
Read MoreBiogen Idec’s ALS drug binned after failed trial
Biogen Idec will discontinue work on its experimental drug dexpramipexole to treat the nerve cell disease amyotrophic lateral sclerosis after a Phase III trial failed to be both efficacious and prolong survival.
Read MoreNICE gives final draft guidance on Lucentis
The UK’s drugs watchdog has recommended NHS use of Lucentis as a treatment for visual impairment caused by diabetic macular oedema after Novartis submitted a revised patient access scheme and new drug data.
Read MoreWellcome Trust launches investment arm
The UK-based Wellcome Trust has launched the new evergreen investment company Syncona Partners to provide capital to life science start-ups.
Read More- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
- CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment
- FDA approves new high dose Spinraza regimen for SMA
